Citadel Advisors’s Beneficient BENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,484
Closed -$10.8K 12769
2025
Q2
$10.8K Buy
+4,484
New +$10.9K ﹤0.01% 12193
2024
Q1
Sell
-28
Closed -$8.76K 14560
2023
Q4
$8.76K Buy
28
+11
+65% +$5.19K ﹤0.01% 13197
2023
Q3
$27.7K Sell
17
-1
-6% -$1.57K ﹤0.01% 12350
2023
Q2
$34.7K Buy
+18
New +$55.9K ﹤0.01% 12203

Other funds holding BENF

Citadel Advisors's BENF Position: Q3 2025 in Review

Citadel Advisors sold out of Beneficient (BENF) in Q3 2025, closing a stake of 4,484 shares — an estimated $10.8K sold.

Citadel Advisors first reported a position in BENF in Q2 2023 and held it in 4 quarters. The position peaked at $34.7K in Q2 2023. 19 funds tracked by Wall St. Rank hold BENF as of Q3 2025.

  • Citadel Advisors reported no remaining Beneficient position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 4,484 Beneficient shares in Q3 2025, an estimated $10.8K.
  • Citadel Advisors first reported a position in Beneficient in Q2 2023 and held it in 4 quarters.
  • Citadel Advisors's Beneficient position peaked at $34.7K in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Beneficient as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.